---
schema_version: "secwatch.filing_event.v1"
accession: "0001193125-24-123758"
form_type: "8-K"
ticker: "IKT"
cik: "0001750149"
company_name: "Inhibikase Therapeutics, Inc."
filed_at: "2024-04-30T23:59:59+00:00"
generated_at: "2026-06-03T04:35:27.049339+00:00"
event_type: "litigation"
sentiment: "negative"
materiality_score: 0.6
calibrated_materiality_score: 0.6
confidence: "high"
source: SEC EDGAR
---

# Inhibikase receives arbitration demand for $1.625M from Pivot over milestone payments

## Summary
- Pivot Holding LLC, successor to Sphaera Pharma, demands $1.625 million plus interest for alleged breach of 2012 collaboration agreement.
- Company believes claims are without merit and will vigorously dispute; intends to assert counterclaims.
- Arbitration proceeding administrated by American Arbitration Association; no timeline for resolution disclosed.

## SEC filing metadata
- accession: 0001193125-24-123758
- form_type: 8-K
- ticker: IKT
- cik: 0001750149
- company_name: Inhibikase Therapeutics, Inc.
- filed_at: 2024-04-30T23:59:59+00:00
- event_type: litigation
- sentiment: negative
- materiality_score: 0.6
- calibrated_materiality_score: 0.6
- confidence: high
- sec_items: 7.01, 8.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1750149/000119312524123758/0001193125-24-123758-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1750149/000119312524123758/d827800d8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001193125-24-123758
- JSON: https://secwatch.observer/filing/0001193125-24-123758.json
- Plain text: https://secwatch.observer/filing/0001193125-24-123758.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.